top of page



FDA’s AI Breakthrough: Why the Mushrooms Inc. subsidiary MYCOLabX Is Positioned for a Fast Regulatory Win
Our mycelium-based smart bandage technology represents a groundbreaking fusion of nature and science—leveraging FDA-regulated pathways to deliver active nutrients while detecting infection through visible color changes. With the FDA’s new AI-assisted review process potentially accelerating approvals, we are entering a transformative era for biotech innovation. Our approach aims to meet urgent healthcare needs in both civilian and military settings with precision and safety at

Kimberly ZAWI Carlson
Jun 122 min read
bottom of page